OraSure partners with Walgreens to promote HIV testing
OraSure Technologies on Thursday announced several new HIV testing-related initiatives in recognition of World AIDS Day. OraSure is working with The AIDS Institute to launch a grant program to encourage the development of HIV self testing programs and collaborating with both The AIDS Institute and Walgreens, based in Deerfield, Ill., to promote rapid HIV testing in cities across the U.S.
Bethlehem, Pa.-based OraSure and Walgreens are launching the OraQuick In-Home HIV Test Retail Access Card, available for public health organizations and advocacy groups across the country to distribute to their at-risk program participants during outreach events. Each card will be redeemable for one OraQuick In-Home HIV Test kit at no cost, at any one of the 8,000+ Walgreens and Duane Reade drugstores nationwide.
“The Walgreens OraQuick HIV Test Retail Access Card will allow public health entities to utilize our expansive retail network to help get in-home HIV tests into the hands of customers who need one,” stated Glen Pietrandoni, senior director, patient care and advocacy at Walgreens. “In collaboration with OraSure, we are looking forward to working with Housing Works as well as other HIV/AIDS advocacy groups across the country as we continue to build on our 35-year history of community support in highly impacted communities.”
Initially, Walgreens and OraSure will provide the OraQuick In-Home HIV Test Retail Access Cards to Housing Works, a New-York City-based public health organization for people living with and affected by HIV/AIDS. And, in honor of World AIDS Day, OraSure, Walgreens and Housing Works will host a free HIV testing event on Dec. 1, from 11 a.m. until 4 p.m. EST at the Duane Reade located at 1430 Broadway in New York City. Free, OraQuick Advance HIV1/2 tests will be offered on a first come, first served basis as space and supplies permit.
"We are very proud to launch several programs aimed squarely at enabling HIV testing in support of World AIDS Day," stated Douglas Michels, president and CEO of OraSure Technologies. "A key challenge to ending HIV is to test as many individuals as possible who have not been previously tested so they can know their status and be linked to care."
In addition to supporting numerous community testing events across the country, OraSure will host the NASDAQ Stock Market Opening Ceremony followed by a special HIV testing industry panel discussion focused on Global Leadership in HIV Self-Testing: Innovative Approaches to Achieve HIV Testing Goals.
The panel discussion will be webcast live here starting at 10 a.m. EST on Dec. 1.
Guests for the NASDAQ market opening ceremony and panel discussion will include Karl Hofmann, president and CEO of Population Services International; Lelio Marmora, executive director, UNITAID; Jeffrey Klausner, professor Medicine and Public Health UCLA David Geffen School of Medicine and Fielding School of Public Health.
Trend toward self-management fuels growth of diabetes device sales
With the increasing trend of self-management and the rising awareness around the diabetes disease state within developing countries, blood glucose meters can be utilized to aid in adjustment of therapeutic regimen in response to blood glucose values and to help patients adjust their dietary intake, physical activity and insulin doses to improve glycaemic control on a regular basis.
This and several other factors are covered in the latest Research and Marekts report focused on diabetes care devices.
The global diabetes care devices market is expected to grow at a CAGR of 5.3% from 2017 to 2022 to reach $26.7 billion Research and Markets reported in its “Diabetes Care Devices Market – Global Opportunity Analysis and Industry Forecast (2017-2022)” report released Thursday.
Increasing prevalence of diabetes, technological advancements, rise in obese population, sedentary lifestyle and improper diet and increasing need for faster and safer diagnosis and treatment of diabetes are the key market drivers covered in the report.
However, high cost associated with diagnosis and treatment, reimbursement issues for new technologies and lack of awareness about the timely care of the disease for its better management are the major pain points, restraining the adoption of the diabetes care devices.
CVS Health to mark National Influenza Vaccination Week
With flu season set to kick into gear soon, CVS Health is marking National Influenza Vaccination Week by reminding patients to get their flu shots. The Centers for Disease Control and Prevention established the week of awareness to remind patients to get vaccinated. The Woonsocket, R.I.-based company recently ran a survey that found that 61% of patients get a flu vaccine every year, or plan to get one this year.
"The influenza virus is highly contagious and can be easily spread through a workplace environment through direct contact with co-workers or infected surfaces," chief nurse practitioner for CVS Health’s MinuteClinic Angela PAtterson said. “Influenza infection can have potentially serious effects and getting vaccinated is vital to staying healthy, especially when working alongside co-workers who may have already contracted the virus.”
The company’s survey also found that among patients planning to get vaccinated, 37% think about convenience, 36% consider doctor recommendations and 35% think about where their insurance is accepted. It also found that 65% of Americans still go to work when feeling ill from flu-like symptoms.
CVS Health noted that most insurance plans cover the flu shot at no cost to patients, and that it offers the vaccine through its more than 9,700 CVS Pharmacy locations and 1,100 MinuteClinic locations. They’re given seven days a week on a walk-in basis. The company said that patients in certain states who get a flu shot at CVS Pharmacy or MinuteClinic will receive a coupon for $5 off a $25 CVS Pharmacy purchase, with patients who get a shot at a Target location in certain states getting a $5 Target coupon.